中文 | English
Return
Total: 1737 , 1/174
Show Home Prev Next End page: GO
Author:(Zhi-Yong LI)

1.Exploring mechanism of Porana racemosa Roxb. in treating rheumatoid arthritis based on integration of network pharmacology and molecular docking combined with experimental validation

Chen-yu YE ; Ning LI ; Yin-zi CHEN ; Tong QU ; Jing HU ; Zhi-yong CHEN ; Hui REN

Acta Pharmaceutica Sinica 2025;60(1):117-129

2.The Invariant Neural Representation of Neurons in Pigeon’s Ventrolateral Mesopallium to Stereoscopic Shadow Shapes

Xiao-Ke NIU ; Meng-Bo ZHANG ; Yan-Yan PENG ; Yong-Hao HAN ; Qing-Yu WANG ; Yi-Xin DENG ; Zhi-Hui LI

Progress in Biochemistry and Biophysics 2025;52(10):2614-2626

3.Clinical trial of remifentanil combined with dexmedetomidine in orthopedic surgery for the elderly patients

Zhi-Min ZHANG ; Yong-Le LI ; Xiao-Long NIU ; Guang-Yi WU ; Ying WANG ; Lu GAN

The Chinese Journal of Clinical Pharmacology 2024;40(2):190-194

4.Mechanism of Yi Sui Sheng Xue Fang in improving renal injury induced by chemotherapy in mice based on Keap1/Nrf2 signaling pathway

Yu LIU ; Li-Ying ZHANG ; Ya-Feng QI ; Yang-Yang LI ; Shang-Zu ZHANG ; Qian XU ; Guo-Xiong HAO ; Fan NIU ; Yong-Qi LIU ; Zhi-Ming ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(5):703-707

5.Effects of emodin modulation of the HIF-1α/VEGF pathway on vascular endothelial cells damage in diabetic macroangiopathy rats

Qiu-Xiao ZHU ; Hui-Yao HAO ; Zi-Bo LIU ; Ming GAO ; Fang ZHANG ; Jing ZHOU ; Zhi-Hua HAO ; Li-Hui ZHANG ; Yong-Mei HAO

The Chinese Journal of Clinical Pharmacology 2024;40(6):859-863

6.Research status on the mechanism of traditional Chinese medicine regulating TGF-β1/Smads signaling pathway to intervene liver fibrosis

Yong-Biao TAO ; Shi-Rui YANG ; Long-De WANG ; Ya-Na WU ; Zhi-Ming ZHANG ; Fu LI

The Chinese Journal of Clinical Pharmacology 2024;40(6):918-922

7.Pathological mechanism of hypoxia-inducible factor-1α in tumours and the current status of research on Chinese medicine intervention

Yu LIU ; Li-Ying ZHANG ; Guo-Xiong HAO ; Ya-Feng QI ; Qian XU ; Ye-Yuan LIU ; Chao YUAN ; Peng ZHU ; Yong-Qi LIU ; Zhi-Ming ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(11):1670-1674

9.GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer.

Qiwei JIANG ; Yong LI ; Songwang CAI ; Xingyuan SHI ; Yang YANG ; Zihao XING ; Zhenjie HE ; Shengte WANG ; Yubin SU ; Meiwan CHEN ; Zhesheng CHEN ; Zhi SHI

Acta Pharmaceutica Sinica B 2024;14(2):698-711

10.Establishment and evaluation methods of a novel animal model of liver depression transforming into fire syndrome-related depression

Dan SU ; Jian LI ; Gen-hua ZHU ; Ming YANG ; Liang-liang LIAO ; Zhi-fu AI ; Hui-zhen LI ; Ya-li LIU ; Yong-gui SONG

Acta Pharmaceutica Sinica 2024;59(6):1680-1690

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1737 , 1/174 Show Home Prev Next End page: GO